Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4281423
Max Phase: Preclinical
Molecular Formula: C27H22F3N3O9S
Molecular Weight: 472.48
Molecule Type: Small molecule
Associated Items:
ID: ALA4281423
Max Phase: Preclinical
Molecular Formula: C27H22F3N3O9S
Molecular Weight: 472.48
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: COc1ccc(-n2n[n+](-c3ccc(OC)c(OC)c3)c3c2C(=O)c2ccccc2C3=O)cc1OC.O=S(=O)([O-])C(F)(F)F
Standard InChI: InChI=1S/C26H22N3O6.CHF3O3S/c1-32-19-11-9-15(13-21(19)34-3)28-23-24(26(31)18-8-6-5-7-17(18)25(23)30)29(27-28)16-10-12-20(33-2)22(14-16)35-4;2-1(3,4)8(5,6)7/h5-14H,1-4H3;(H,5,6,7)/q+1;/p-1
Standard InChI Key: PVLBKKUMXXOTHZ-UHFFFAOYSA-M
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 472.48 | Molecular Weight (Monoisotopic): 472.1503 | AlogP: 2.96 | #Rotatable Bonds: 6 |
Polar Surface Area: 92.76 | Molecular Species: NEUTRAL | HBA: 8 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 9 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 0.99 | CX LogD: 0.99 |
Aromatic Rings: 4 | Heavy Atoms: 35 | QED Weighted: 0.35 | Np Likeness Score: -0.31 |
1. Subedi YP, Alfindee MN, Shrestha JP, Chang CT.. (2018) Tuning the biological activity of cationic anthraquinone analogues specifically toward Staphylococcus aureus., 157 [PMID:30130717] [10.1016/j.ejmech.2018.08.018] |
Source(1):